Acasti Pharma, Inc. (ACST) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cumberland Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc.

Indaptus Therapeutics, Inc.

Context Therapeutics, Inc.

Acasti Pharma, Inc.

KALA BIO, Inc.

AIM ImmunoTech, Inc.

Genprex, Inc.

Alzamend Neuro, Inc.

Vincerx Pharma, Inc.

NLS Pharmaceutics Ltd.

Why is Acasti Pharma, Inc. ?

Unrated Stock - No Analysis Available

Real-Time Research Report

Verdict Report

No Data Found

Is Acasti Pharma, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Acasti Pharma, Inc.

-31.83%

-0.49

69.26%

S&P 500

15.76%

1.22

13.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-1.65%

EBIT Growth (5y)

4.56%

EBIT to Interest (avg)

-19.80

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.33

Sales to Capital Employed (avg)

0.00

Tax Ratio

25.06%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

27.99%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.11

EV to EBIT

-4.76

EV to EBITDA

-4.77

EV to Capital Employed

1.16

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-24.34%

ROE (Latest)

-14.67%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

6What is working for the Company

NET PROFIT(HY)

Higher at USD -3.44 MM

RAW MATERIAL COST(Y)

Fallen by 0% (YoY

OPERATING PROFIT(Q)

Highest at USD -2.38 MM

PRE-TAX PROFIT(Q)

Highest at USD -2.26 MM

-4What is not working for the Company

ROCE(HY)

Lowest at -36.19%

CASH AND EQV(HY)

Lowest at USD 30.73 MM

EPS(Q)

Lowest at USD -0.91

Here's what is working for Acasti Pharma, Inc.

Net Profit

Higher at USD -3.44 MM

than preceding 12 month period ended Jun 2026

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Operating Profit

Highest at USD -2.38 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit

Highest at USD -2.26 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Raw Material Cost

Fallen by 0% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Acasti Pharma, Inc.

EPS

Lowest at USD -0.91

in the last five periods

MOJO Watch

Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Cash and Eqv

Lowest at USD 30.73 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents